In addition, colon cancer cell lines with elevated YAP activity are resistant to 5-fluorouracil[118], and breast cancer cell lines expressing activated TAZ are more resistant to doxorubicin/paclitaxel [49] and taxol treatment [119]. This evidence concerns the gene YAP1 and malignant colon neoplasm.